Standardized Intravenous Nutrition Linked to Low Sodium
The strong low-sodium association warrants further investigation of this standardized nutrition regimen, but the small, non-randomized comparison cannot separate the regimen’s contribution from differences in babies or care over time.
Evidence
Standardized intravenous nutrition was strongly associated with low blood sodium in preterm babies at one neonatal intensive care unit. The association remained after statistical adjustment, but the study does not establish that the nutrition regimen caused the abnormality.
Parenteral nutrition delivers nutrients directly into a vein. In the preterm-infant nutrition study, published October 5, 2026, researchers retrospectively compared sequential groups before and after a switch from individually tailored nutrition to a standardized formulation. There were 362 babies in the individualized group and 33 in the standardized group. Eligibility included gestational age of 34 weeks or less and/or birth weight of 1,500 grams or less.
Clinical information had been recorded prospectively. Researchers collected daily nutrition intake and blood measurements during the first week of life and used four separate statistical models to examine sodium, potassium, calcium and phosphate abnormalities.
The adjusted odds ratio for low blood sodium was 38.9. This compares odds between groups after accounting for other measured factors; it does not mean 38.9 times as many babies were affected. In the low-sodium model, 31 of the 33 babies receiving standardized nutrition had low sodium.
Standardized nutrition was also associated with higher adjusted odds of high blood phosphate, low blood calcium and high blood potassium, with odds ratios of 7.1, 4.1 and 2.5, respectively. Sodium and calcium intakes were significantly lower in the standardized group during the first week.
Analysis
Interpretation: Lower sodium and calcium delivery is a possible explanation for the corresponding blood abnormalities, but the study did not demonstrate that mechanism. The intake measurements and blood tests identify a question about how this particular formulation matched these infants’ needs—not proof that standardized formulations generally perform worse than individualized nutrition.
These findings come from one study. The different blood abnormalities are related observations within that cohort, not independent confirmation of the low-sodium finding.
Limitations
Treatment was not randomly assigned, and the groups were treated in different periods. Differences in patient characteristics or care over time could therefore contribute to the associations despite statistical adjustment.
The standardized group contained only 33 babies, compared with 362 receiving individualized nutrition. That imbalance limits statistical confidence, while the single-center setting limits generalization. The large sodium odds ratio should not be interpreted as an equally large increase in the percentage affected.
The high-potassium comparison had reported post-hoc statistical power of 55.7%—a retrospective estimate of its ability to detect an assumed effect. That finding should remain hypothesis-generating rather than support a firm conclusion.
What to watch
A larger comparison treating both groups during the same period should measure sodium intake and report low-sodium event rates in each group, alongside confidence intervals—the ranges expressing uncertainty around effect estimates. Reproduction of a large low-sodium association across centers would strengthen confidence; substantial attenuation after accounting for differences in infants and care would weaken it.